Trevena, Inc. - TRVN Net earnings per share (EPS TTM)
Trevena, Inc. (TRVN) develops innovative analgesics, offering Olinvyk as a safe alternative to opioids for intensive care units. The business model relies on outsourcing production and trials to minimize capital expenditures. However, sluggish demand for the drug has led to stagnation and strict austerity measures. The 12-month EPS trend captures profitability, where -55.96 indicates the value of this parameter.
Analytical breakdowns for Trevena, Inc (TRVN)
- share price and expert price forecast:
- issuer market value details:
- business book valuation details:
- debt and liquidity details:
Total Debt to Equity Ratio Trevena, Inc.|TRVN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital trevena.com|TRVN - Company Total Debt Obligations|Debt to Book Capitalization Ratio Trevena|TRVN - Company Long-Term Indebtedness|Company Short-Term Debts Trevena|Quick Liquidity Indicator trevena.com
- earnings and multiples data:
TRVN - Net Financial Result|Future Profit Trevena, Inc.|TRVN - Market Price to Net Income Ratio|Future Price to Earnings Trevena, Inc|TRVN - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Trevena, Inc|TRVN - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Trevena|TRVN - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months trevena.com|TRVN - Earnings per share growth this year|Earnings growth forecast for next year Trevena, Inc.
- sales volume and revenue information:
Fundamental company analysis:TRVN - Trevena, Inc
The metric's calculation formula directly reflects the difference between operating revenue and total expenses. This indicator measures net income allocated per share over a trailing twelve-month period, assessing the actual return on capital. At Trevena, Inc. (TRVN), high fixed costs coupled with scaled-back commercial programs suppress this result. The current liquidity deficit blocks profit growth. The TTM earnings per share trend confirms business stagnation.
Direct competitors
biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year
